Mo Li on PARP inhibitors

eBioMedicine in conversation with

Content provided by The Lancet Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3M ago 15:59

MP3•Episode home

Dr. Mo Li from Peking University Third Hospital discusses his publication "PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response".
Read the full article:
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00164-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

24 episodes

#Science #Biology #Fitness #Medicine #Podcasting Education #The Lancet Group #Microplastics #Diversity

Mo Li on PARP inhibitors

eBioMedicine in conversation with

published 3M ago

MP3•Episode home

24 episodes

#Science #Biology #Fitness #Medicine #Podcasting Education #The Lancet Group #Microplastics #Diversity

All episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.